Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Related Articles by Review for PubMed (Select 18978127)

1.

ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.

Obstet Gynecol. 2008 Nov;112(5):1189-92. doi: 10.1097/AOG.0b013e31818e8782.

PMID:
18978127
2.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

PMID:
15963666
3.

Alternative hormone replacement regimens: is there a need for further clinical trials?

Welty FK.

Curr Opin Lipidol. 2003 Dec;14(6):585-91. Review.

PMID:
14624135
4.

A comparative review of the risks and benefits of hormone replacement therapy regimens.

Warren MP.

Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. Review.

PMID:
15118656
5.

Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.

Romero M.

Adv Nurse Pract. 2002 Nov;10(11):47-8, 51-2. Review. No abstract available.

PMID:
12478948
6.

Hormone replacement therapy update: who should we be prescribing this to now?

Kocjan T, Prelevic GM.

Curr Opin Obstet Gynecol. 2003 Dec;15(6):459-64. Review.

PMID:
14624210
7.

Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.

van der Mooren MJ, Kenemans P.

Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):123-4. Review. No abstract available.

PMID:
12648855
8.

Estrogen with and without progestin: benefits and risks of short-term use.

LaCroix AZ.

Am J Med. 2005 Dec 19;118 Suppl 12B:79-87.

PMID:
16414331
9.

Hormone therapy and the cardiovascular system: the critical role of progestins.

Sitruk-Ware RL.

Climacteric. 2003 Oct;6 Suppl 3:21-8. Review.

PMID:
15018245
10.

Menopausal hormone therapy.

Bhavnani BR, Strickler RC.

J Obstet Gynaecol Can. 2005 Feb;27(2):137-62. Review.

PMID:
15937590
11.

[Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate].

Ortmann J, Traupe T, Vetter W, Barton M.

Praxis (Bern 1994). 2004 May 19;93(21):904-14. Review. German.

PMID:
15216975
12.

Benefits and risks of menopausal estrogen and/or progestin hormone use.

Ernster VL, Bush TL, Huggins GR, Hulka BS, Kelsey JL, Schottenfeld D.

Prev Med. 1988 Mar;17(2):201-23. Review.

PMID:
2843846
13.
14.

Estrogen and progestogen effect on venous thromboembolism in menopausal women.

Archer DF, Oger E.

Climacteric. 2012 Jun;15(3):235-40. doi: 10.3109/13697137.2012.664401. Review.

PMID:
22612609
15.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
16.

Impact of WHI conclusions and ACOG guidelines on clinical practice.

Gass M.

Int J Fertil Womens Med. 2003 May-Jun;48(3):106-10; discussion 137-8. Review.

PMID:
12839140
17.

Hormones and coronary atherosclerosis in women.

Rackley CE.

Endocrine. 2004 Aug;24(3):245-50. Review.

PMID:
15542892
18.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Prentice RL.

Semin Reprod Med. 2014 Nov;32(6):419-25. doi: 10.1055/s-0034-1384624. Epub 2014 Oct 16. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk